{"id":8291,"date":"2016-07-14T14:02:05","date_gmt":"2016-07-14T14:02:05","guid":{"rendered":"\/articles\/?p=8291"},"modified":"2016-07-14T14:15:05","modified_gmt":"2016-07-14T14:15:05","slug":"emispehere-technologies-inc-otcmktsemis-falls-back-down","status":"publish","type":"post","link":"\/articles\/emispehere-technologies-inc-otcmktsemis-falls-back-down\/","title":{"rendered":"Emispehere Technologies, Inc. (OTCMKTS:EMIS) Falls Back Down"},"content":{"rendered":"<p>tags: EMIS <\/p>\n<p><img loading=\"lazy\" decoding=\"async\" style=\"float: right;\" src=\"\/\/s.hotstocked.com\/hotstocked.com\/repository\/articles\/93\/93913\/emis_6m_450x350.png\" border=\"0\" width=\"407\" height=\"172\" \/><\/p>\n<p>All it took was a single session for the stock of Emisphere Technologies, Inc. (OTCMKTS:<a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=EMIS\">EMIS<\/a>) to wipe the entirety of its gains from the previous two sessions. The ticker finished the trading day with a 7% correction at 74 cents per share. The losses could have been far scarier with <strong><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=EMIS\">EMIS<\/a> <\/strong>falling all the way down to a intraday low of $0.64 but it managed to retrace most of its steps back up in last hours of the session.<\/p>\n<p>Just a little over a month ago <strong>Emisphere <\/strong>actually climbed to new 52-week high of over 90 cents but currently they are sitting close to 19% lower. At first glance the underwhelming chart performance might seem rather surprising. After all, <strong><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=EMIS\">EMIS<\/a> <\/strong>has financials that set it apart from the vast majority of pennystock ventures. The company finished the first quarter of the year with:<\/p>\n<p>&bull; $10.4 million cash<br \/>&bull; $12.7 million total current assets<br \/>&bull; $21.7 million total current liabilities<br \/>&bull; $373 thousand net revenues<br \/>&bull; $1.8 million net loss<\/p>\n<p>During the first quarter Novo Nordisk (NYSE:NVO) launched a Phase 3a clinical trials for oral semaglutide that are going to utilize <strong>Emispehre&#8217;s <\/strong><em>Eligen <\/em>carriers. During the Phase 3 program 9,300 patients are expected to be enrolled in ten clinical studies. Back in October 2015 <strong><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=EMIS\">EMIS<\/a> <\/strong>amended their agreement with NVO and as a result received a total payment of $14 million.<\/p>\n<p>Here is where the problems start, though. Under the terms of the company&rsquo;s convertible reimbursement promissory notes, secured loan agreement and royalty agreement <strong><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=EMIS\">EMIS<\/a> <\/strong>is required to use 50% of certain proceed, which included the $14 million from NVO, as a prepayment of certain outstanding amounts of the reimbursement notes and the loan agreement. This would leave <strong><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=EMIS\">EMIS<\/a> <\/strong>with extremely limited financial resources. The date by which the prepayment should have been made was extended to June 13 but in an 8-K filing submitted on June 17 <strong><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=EMIS\">EMIS<\/a> <\/strong>announced a further extension to July 13, period that ends &hellip; today.<\/p>\n<p>The stock of the company could continue to display heightened volatility in the coming sessions. Plan you trades carefully and always do your own due diligence.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>tags: EMIS All it took was a single session for the stock of Emisphere Technologies, Inc. (OTCMKTS:EMIS) to wipe the entirety of its gains from the previous two sessions. The ticker finished the trading&#46;&#46;&#46;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-8291","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts\/8291","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/comments?post=8291"}],"version-history":[{"count":0,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts\/8291\/revisions"}],"wp:attachment":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/media?parent=8291"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/categories?post=8291"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/tags?post=8291"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}